Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 83,359 shares at $8.19 ($694K) on 2024-07-31, disclosed to the SEC on 2024-07-31.
Scheduled sale ($694k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.51 | 12,164 | $104K | 14.9% |
| 2 | $8.51 | 12,164 | $104K | 14.9% |
| 3 | $8.85 | 1,359 | $12K | 1.7% |
| 4 | $8.28 | 15,128 | $125K | 18.0% |
| 5 | $8.28 | 15,128 | $125K | 18.0% |
| 6 | $8.19 | 13,708 |
| $112K |
| 16.2% |
| 7 | $8.19 | 13,708 | $112K | 16.2% |
| Total | $8.33 avg | 83,359 | $694K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |